Case report: Durable response of ensartinib targeting EML4-ALK fusion in osimertinib-resistant non-small cell lung cancer

Overview of attention for article published in Frontiers in Pharmacology, July 2024

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

reddit: 2 Redditors

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 1 Mendeley

Summary Reddit Dimensions citations

So far, Altmetric has seen 2 Reddit threads by 2 users.

Frontiers | Case report: Durable response of ensartinib targeting EML4-ALK fusion in osimertinib-resistant non-small cell lung cancer

User WalkingHorse, in the LungCancerSupport subreddit, 29 Jul 2024

Case report: Durable Response of Ensartinib Targeting EML4-ALK Fusion in Osimertinib-resistant Non-small Cell Lung Cancer

User montaukwhaler, in the non small cell lung cancer subreddit, 09 Jul 2024

This page shows the most recent Reddit threads that mention this research output.

Click here to find out how to access more activity.